Effects of Continuous Venous Dialysis & Hemodialysis on Fluid Dynamics by

Status Completed

Clinical Trial Summary

Dialysis methods applied at the bedside and dialysis methods applied in hemodialysis unit are widely applied in patients with renal insufficiency. Especially hemodynamically affected patients are less affected by hemodynamics as a result of using dialysis methods. It is a completely non-invasive method by bioreactance method and it can be done to measure the intra-body fluid status with the help of the glued probes. The aim of this study is to investigate the effects of continuous venous dialysis and hemodialysis on the fluid dynamics applied at the bedside with bioreactance method. In this way, the patient can develop more comfortable hemodynamic changes. Patients in the Surgery, Reanimation and Postoperative Intensive Care Unit with more than 24 hours of hospitalization and bedside dialysis or hemodialysis will be included in the study. Before the dialysis, body fluid measurements will be made with bioreactance, and after dialysis in patients receiving hemodialysis, and in dialysis patients 6, 12, 24 and 36 hours.

Clinical Trial Description

Dialysis methods applied at the bedside and dialysis methods applied in hemodialysis unit are widely applied in patients with renal insufficiency. Especially hemodynamically affected patients are less affected by hemodynamics as a result of using dialysis methods. Dialysis in the hemodialysis unit is a method used in intensive care patients and is preferred especially in patients with stable hemodynamics. In dialysis methods, changes occur frequently in the body fluids of the patient. It is a completely non-invasive method by bioreactance method and it can be done to measure the intra-body fluid status with the help of the glued probes. The aim of this study is to investigate the effects of continuous venous dialysis and hemodialysis on the fluid dynamics applied at the bedside with bioreactance method. As a result of measurements with buioreactans method, fluid balance in patients will be understood more easily. In this way, the patient can develop more comfortable hemodynamic changes. Patients in the Surgery, Reanimation and Postoperative Intensive Care Unit with more than 24 hours of hospitalization and bedside dialysis or hemodialysis will be included in the study. Before the dialysis, body fluid measurements will be made with bioreactance, and after dialysis in patients receiving hemodialysis, and in dialysis patients 6, 12, 24 and 36 hours. ;

Study Design

Related Conditions & MeSH terms

Renal Dialysis

Clinical Trial Details

NCT number	NCT03905122
Study type	Observational
Source	Trakya University
Contact
Status	Completed
Phase
Start date	June 15, 2018
Completion date	June 15, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05189795` - The Construction of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients
Completed	`NCT01125202` - Intervention to Reduce Dietary Sodium in Hemodialysis	N/A
Completed	`NCT00753116` - Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension	Phase 1
Completed	`NCT00806130` - Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients
Completed	`NCT00730145` - A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis	Phase 1
Completed	`NCT05718765` - The Effect of Physical ACtivity Enhancement Scheme (PACES) in Hemodialysis Patients	N/A
Completed	`NCT03250715` - Effects of Low Level Laser Therapy on Functional Capacity and DNA Damage of Patients With Chronic Kidney Failure	N/A
Completed	`NCT05469620` - Adaptive Nutrition Therapy in Hemodialysis	N/A
Completed	`NCT03536858` - Social Networks and Renal Education: Promoting Transplantation	N/A
Completed	`NCT00824837` - Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane	Phase 1/Phase 2
Completed	`NCT03403491` - Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis	N/A
Terminated	`NCT02495662` - The LIPMAT Study: Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation	Phase 2
Completed	`NCT01179620` - Certoparin in Renal Patients Undergoing Hemodialysis	Phase 3
Completed	`NCT01017276` - A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis	Phase 3
Active, not recruiting	`NCT04466865` - A Communication Tool to Assist Older Adults Facing Dialysis Choices	N/A
Recruiting	`NCT03782519` - Quality of Life of Frail Aged Patients in Incremental Hemodialysis	N/A
Recruiting	`NCT02843334` - Study of the Prevalence of Fabry Disease in French Dialysis Patients	N/A
Recruiting	`NCT02545530` - Transdermal Clonidine in Chronic Hemodialysis Patients	N/A
Completed	`NCT00892749` - Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis	Phase 3
Completed	`NCT00649298` - A Clinical Trial of IntensiVE Dialysis	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Continuous Venous Dialysis and Hemodialysis on Fluid Dynamics by Bioreactance Method

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms